How much funding has Pathos raised?

Pathos has raised $365.0M in total funding, most recently a Series D round.

Where is Pathos headquartered?

Pathos is headquartered in Chicago, Illinois, United States.

What industry is Pathos in?

Pathos operates in Artificial Intelligence, Biotech, Oncology, Healthcare.

Pathos

Where the Future of Drug Development Begins

Chicago, United States · Founded 2020 · $365.0M raised

Artificial Intelligence

Biotech

Oncology

Healthcare

Headquarters: Chicago, Illinois
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: pathos.ai
Total Funding: $365.0M
Last Round: $365.0M Series DMay 2025
Rounds: 1

About

Pathos is an AI-enabled clinical-stage biotech re-engineering drug development for precision oncology. Using the largest multimodal oncology dataset and thousands of AI agents, we simulate trials, identify responsive patient subgroups, and accelerate therapies from hypothesis to clinic. Our platform de-risks development, improves success rates, and delivers better outcomes faster.

Summary

Pathos is an Artificial Intelligence company based in Chicago, United States, founded in 2020. It has raised $365.0M in total across 1 round, most recently a $365.0M Series D round in May 2025.